Broker's calls

Broker's Calls

Analysts like CapitaLand Ascendas REIT’s defensive attributes; Maybank upgrades to ‘buy’

The analysts' target prices range from $2.65 to $3.06.

Broker's Calls

Analysts mixed on UOB’s outlook after 3QFY2023 results

Analysts' target prices range from $29.70 to $35.90.

Broker's Calls

DBS upgrades OUE Commercial REIT to ‘buy’ as hospitality sector recovers ahead of expectations

DBS's target price of 35 cents on the REIT implies a target yield of 6% and 0.6x P/NAV.
Analysts trim estimates and TPs on FCT after 2HFY2023 and FY2023 results - THE EDGE SINGAPORE

Broker's Calls

Analysts trim estimates and TPs on FCT after 2HFY2023 and FY2023 results

The analysts' target prices range from $2.12 to $2.60.

Broker's Calls

Maybank lowers Mapletree Logistics Trust’s TP to $1.60 after factoring in higher cost of equity

The analyst has kept his "buy" call due to the REIT’s “disciplined execution” and network of warehouses in the region.
Maybank Securities maintains 'buy' call on FEHT on distribution stability and robust outlook - THE EDGE SINGAPORE

Broker's Calls

Maybank Securities maintains 'buy' call on FEHT on distribution stability and robust outlook

'FEHT offers a stable distribution profile and a lowly geared balance sheet'
Analysts mostly negative on Suntec REIT after 3QFY2023 business update; TPs range from $1.10 to $1.47 - THE EDGE SINGAPORE

Broker's Calls

Analysts mostly negative on Suntec REIT after 3QFY2023 business update; TPs range from $1.10 to $1.47

PhillipCapital was the only brokerage to keep its ‘buy’ call and target price unchanged at $1.47.

Broker's Calls

UOB Kay Hian keeps ‘buy’ call on Raffles Medical but with lower TP of $1.47 upon Vietnam entry

The analysts say they see downside risks to their FY2023 to FY2025 revenue and earnings estimates for the group. Here's why.
Analysts lower Sea Limited’s TP ahead of 3QFY2023 results - THE EDGE SINGAPORE

Broker's Calls

Analysts lower Sea Limited’s TP ahead of 3QFY2023 results

Analysts from DBS and UOB Kay Hian have lowered their target prices to US$70 and US$72.25 respectively.
×